This website describes Equisculpt Novem Fund - the brand name of Novem Prime Incorporated VCC Sub-Fund, a sub-fund of the umbrella vehicle Equisculpt Novem Capital VCC, a Mauritius variable capital company holding a Global Business Licence issued by the Financial Services Commission, Mauritius. It is provided for information only and does not constitute an offer, solicitation or investment advice.
The fund is available exclusively to eligible investors who meet applicable qualification requirements, on the basis of its confidential offering documents. It is not open to residents of India under the Indian FEMA and SEBI FPI frameworks, and nothing on this site is directed at any person in a jurisdiction where such distribution would be unlawful.
Past performance - including the track record of related entities - is not indicative of future results. Investment involves risk, including possible loss of capital.
Please read this notice carefully. By using this website you accept the terms below.
This website is provided for information only. Nothing on it constitutes an offer to sell, or a solicitation of an offer to buy, any security or investment product, nor investment, legal or tax advice. Any offer or solicitation will be made only through the fund’s confidential offering documents, which alone govern any investment and which are available exclusively to eligible investors.
Equisculpt Novem Fund is available exclusively to investors who meet applicable qualification and eligibility requirements, determined case by case following KYC/AML and suitability checks. This website is not directed at any person in any jurisdiction where its publication or availability would be contrary to local law or regulation.
As a Mauritius foreign portfolio investment structure, the fund cannot accept India-resident investors under the Indian Foreign Exchange Management Act (FEMA) and the SEBI FPI framework. Nothing on this website is directed at residents of India. Non-resident Indians and overseas citizens of India may participate through the NRI or global-citizen route, subject to eligibility.
Performance figures presented on this website relate to the advisory activity of the Equisculpt Ventures group, a related entity, and not to Equisculpt Novem Fund, which is recently constituted and has no operating history of its own. Anchor IPO figures are verifiable against public NSE Emerge and BSE SME filings; group blended XIRR and private/pre-IPO marks are manager-computed and not independently verified. Unrealised marks on open positions are indicative values, not returns, and may not be realisable. Past performance is not indicative of future results.
Target corpus, target returns and similar figures are objectives under the fund’s investment policy. They are not projections, forecasts or guarantees. Investment involves significant risk, including possible loss of the entire capital invested. Pre-IPO, SME and small-cap securities are illiquid and volatile.
“Equisculpt Novem Fund” is the brand name of Novem Prime Incorporated VCC Sub-Fund, registered with the Registrar of Companies, Mauritius (No. C234119), a sub-fund of the umbrella vehicle Equisculpt Novem Capital VCC. Registered office: Vivea Business Park, Block 8, 1827 Building, Moka 80840, Republic of Mauritius. Equisculpt Novem Capital VCC holds a Global Business Licence (No. GB26205965) issued by the Financial Services Commission, Mauritius, and is authorised as a VCC fund under the Variable Capital Companies Act 2022. The licence does not constitute an endorsement by the Commission of the fund’s performance or prospects. Novem Prime Incorporated VCC Sub-Fund is registered with the Registrar of Companies, Mauritius (No. C234119), and is registered with the Securities and Exchange Board of India (SEBI) as a Foreign Portfolio Investor, Category I (Registration No. INMUFP064926).
Content is provided in good faith as at the date of publication and may change without notice. No representation or warranty, express or implied, is made as to its accuracy or completeness. Third-party market statistics are from sources believed reliable but not independently verified.
For questions regarding this notice, contact ir@novemfund.com.